Kyntra Bio KYNB
NASDAQ KYNB
$5.13 -0.09 (-1.63%)
As of: Oct 22, 2026 · 3:59 PM EDT

Kyntra Bio (KYNB) Liabilities from Discontinued Operations (2023 - 2025)

Updated

Kyntra Bio (KYNB) recorded Liabilities from Discontinued Operations of $156,000 in Q2 2025, down 17.5% from the prior quarter.

Analysis

Kyntra Bio (KYNB) Liabilities from Discontinued Operations (2023 - 2025) Analysis & Trends

At the end of FY2024, Kyntra Bio reported Liabilities from Discontinued Operations of $356,000, down 76.3% from FY2023.

  • Across earlier years, Liabilities from Discontinued Operations came in at $1.5 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Kyntra Bio 20.58 Mn -387.36 Mn 1.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 156,000.00
Mar 31, 2025 189,000.00
Dec 31, 2024 356,000.00
Dec 31, 2023 1.50 Mn
API Access

Kyntra Bio Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=KYNB&period=max&api_key=YOUR_API_KEY